Initially, CCN2 was designated connective tissue growth factor (CTGF), owing to its mitogenic activity in fibroblasts [1], whereas the original name of CCN3 was nephroblastoma-overexpressed (NOV), since it was found to be overexpressed in a truncated form in nephroblastomas [2]. The gene discussed is CCN2; the disease is Wilms tumor.